KONZ

konz-logo

Konz is a logistic firm that offers a wide range of services such as order services, floor logistics, pre-order picking and van rentals.

#Website #More

KONZ

Social Links:

Industry:
Logistics Rental Transportation

Founded:
1919-01-01

Address:
Waiblingen, Baden-Wurttemberg, Germany

Country:
Germany

Website Url:
http://www.konz.com

Total Employee:
251+

Status:
Active

Contact:
+49 7151 149100

Email Addresses:
[email protected]

Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS YouTube Privacy Enchanced


Official Site Inspections

http://www.konz.com

  • Host name: 80-92-65-188.ip.dclux.com
  • IP address: 80.92.65.188
  • Location: Luxembourg
  • Latitude: 49.4986
  • Longitude: 5.9784
  • Timezone: Europe/Luxembourg

Loading ...

More informations about "Konz"

Pfizer pulls the plug on 11 programs

6 days ago Pfizer is axing 11 programs, including two pipeline assets from its Seagen buy, work on a BioNTech-partnered mRNA vaccine and a midstage MASH combo.See details»

Press Releases - Pfizer

10.13.2025 Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025 10.09.2025 Pfizer Declares Fourth-Quarter 2025 Dividend โ€ฆSee details»

Pfizer Reports Solid Third-Quarter 2025 Results; Raises and โ€ฆ

6 days ago Pfizer Inc. reported financial results for the third quarter of 2025 and reaffirmed its 2025 Revenue guidance while raising and narrowing guidance for Adjusted diluted EPS. โ€œI am โ€ฆSee details»

Pfizer Q3 2025 earnings beat forecasts as non-COVID drug sales โ€ฆ

Nov 4, 2025 Find out how Pfizer beat Q3 2025 earnings forecasts and raised full-year EPS guidance as non-COVID drugs and cost savings drove profit growth.See details»

Pfizer Earnings Q3 2025 | PFE News & Analysis - panabee.com

Nov 4, 2025 PFE financials: Guru Focus - Yahoo! Pfizer 8-K Pfizer Press release on Q3 financial results Pfizer Strategic Pivot and Earnings Update FAQ Why is this newsworthy? The โ€ฆSee details»

Pfizer won its fight to buy an obesity-drug maker. It took an extra โ€ฆ

21 hours ago Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call. Provided by Dow Jones Nov 10, 2025, 5:05:00 AMSee details»

Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat

6 days ago Pfizer Inc. (PFE) on Tuesday raised its full-year adjusted earnings guidance to a range of $3.00 to $3.15, citing continued confidence in the business and progress with โ€ฆSee details»

Earnings call transcript: Pfizerโ€™s Q3 2025 EPS beats expectations ...

6 days ago Full transcript - Pfizer (PFE) Q3 2025: Dave Denton, CFO, Pfizer: Good day, everyone, and welcome to Pfizerโ€™s third-quarter 2025 earnings conference call. Todayโ€™s call is โ€ฆSee details»

Key facts: Pfizer's merger set for November 2025; deal

3 days ago Pfizer's merger is expected to finalize after a stockholder meeting on November 13, 2025, with strong Board support despite potential legal challenges from Novo Nordisk. 1 Pfizer โ€ฆSee details»

Pfizer and Metsera Enter into Merger Agreement Amendment; โ€ฆ

3 days ago This release contains forward-looking information about, among other topics, Pfizer's proposed acquisition of Metsera, Pfizer's and Metsera's pipeline products, including their โ€ฆSee details»

Pfizerโ€™s Solid Q3 2025 Performance

Nov 4, 2025 Pfizer achieved another quarter of solid financial performance in the third quarter of 2025 โ€“ demonstrating disciplined operational execution while achieving a series of pivotal โ€ฆSee details»

Why Pfizer's 7%-Yielding Dividend Just Became Safer - FINVIZ.com

5 days ago The company also reported good news in its third-quarter update earlier this week. Here are four reasons why Pfizer's dividend just became safer -- and more tempting.See details»

Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent โ€ฆ

Jan 14, 2025 Looking at the period from 2025 to 2030, Pfizer is facing a significant loss of exclusivity (LOE) wave that will reduce revenues by about $17-18 billion between 2026 and 2028.See details»

Pfizer and Metsera Enter into Merger Agreement Amendment; โ€ฆ

3 days ago NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) today announced that it has entered into an amended merger agreement with Pfizer, pursuant to โ€ฆSee details»

Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 ...

Nov 4, 2025 Pfizer (PFE) Price Prediction 2025โ€“2030 The current consensus one-year price target for Pfizer, according to analysts, is $28.60, which represents 15.97% potential upside โ€ฆSee details»

Pfizer Inc. (NYSE:PFE) Q3 2025 Earnings Call Transcript

5 days ago Pfizer Inc. (NYSE:PFE) Q3 2025 Earnings Call Transcript Published on November 5, 2025 at 8:24 am by Insider Monkey Transcripts in News, TranscriptsSee details»

Updates and Statements - Pfizer

June 2025 06.13.2025 Pfizer Provides Update on U.S. Regulatory Review of TALZENNA in Combination with XTANDI for Broader Use in Metastatic Castration-Resistant Prostate Cancer โ€ฆSee details»

Pfizer COVID-19 vaccine sales tumble after government guidance โ€ฆ

6 days ago The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who โ€ฆSee details»

Pfizer is losing its fight with Novo Nordisk to get back in the โ€ฆ

6 days ago Pfizer's buyout bid for Metsera was deemed inferior to the latest bid from Novo Nordisk, putting the original agreement in doubt despite legal efforts to enforce it.See details»

Pfizer's 2025 COVID vaccine boosts immunity 4x, access severely โ€ฆ

1 day ago Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans unable to access the shots.See details»